ABBOTT LABORATORIES holding history
As of Nov. 6, 2026 (UTC)
| March 31, 2025 | 6,073,765 | $805,684,927 | 3.69% | Withheld — Comparison unavailable: Comparable change withheld pending corporate-action review | May 6, 2025 |
| June 30, 2025 | 5,912,808 | $804,201,016 | 3.70% | Withheld — Comparison unavailable: Comparable change withheld pending corporate-action review | Aug. 12, 2025 |
| Sept. 30, 2025 | 5,603,583 | $750,543,907 | 3.56% | Withheld — Comparison unavailable: Comparable change withheld pending corporate-action review | Nov. 5, 2025 |
| Dec. 31, 2025 | 5,169,513 | $647,688,284 | 3.32% | Withheld — Comparison unavailable: Comparable change withheld pending corporate-action review | Feb. 6, 2026 |
| March 31, 2026 | 5,378,840 | $552,245,503 | 3.45% | Withheld — Comparison unavailable: Comparable change withheld pending corporate-action review | May 7, 2026 |
| June 30, 2026 | 4,936,774 | $447,962,873 | 3.59% | Withheld — Comparison unavailable: Comparable change withheld pending corporate-action review | Aug. 6, 2026 |
6 rows · Sort by column; scroll horizontally for more.
No rows match these filters.
Schedule 13G disclosures
No verified related disclosures are included in this freeze.
About reported holdings
13F reports quarter-end securities, excluding cash and shorts. Position changes do not establish trades, motives or returns; portfolio weights use disclosed 13F value.